Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 25 Aug 2025 for Calidi Biotherapeutics, Inc., €215k.
Filing timeline
BuySaleScott Leftwich
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
Closed purchases
Market purchases
1
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -95.0%Entry US$27.20 · Close at T+365 US$1.35
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Scott Leftwich: trading record in brief
This profile gathers the share dealings of Scott Leftwich in Calidi Biotherapeutics, Inc. Over a trading history stretching from 21 December 2023 to 21 August 2025, the count stands at 5 filings.
The open-market record is one-sided, with 1 purchase worth €215k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 4 share grants. 2025 to date brings 1 purchase and no sales.
On 25 August 2025 came the latest disclosure, an open-market purchase for €215k in Calidi Biotherapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Scott Leftwich
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
125,000 shares@ US$2.0093.6% of flowCommon StockSEC:0001641172-25-025446:0
Canonical exit: 19 Nov 2025 (T+90)
11,684 sharesCommon StockSEC:0001493152-25-000302:0
23,783 sharesCommon StockSEC:0001493152-24-026111:0
67,187 sharesCommon StockSEC:0001493152-24-026117:0
8,958 shares@ US$1.806.4% of flowCommon StockSEC:0001493152-24-001132:0
5 of 5 declarations
